Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Rotigotine, Atc N04bc09, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Brodalumab, Atc L04ac12, 67304 Eisenberg Rhineland-palatinate 2026-04-15
Germany Open House Drug Discount Agreements Pegfilgrastim, Atc L03aa13 2026-04-15
Germany Openhouse Biological Abatt Agreements 202528 Abatacept 2026-04-15
Germany The Conclusion Of A Non-exclusive Discount Agreement Pursuant To § 130a Abs.8 Sgb V On The Active Substance Sumatriptan (except Film Tablets And Tablets), Atc N02cc01 For The Period 01.12.2025 - 30.11.2027 2026-04-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Tocilizumab For The Period From 01.12.2025 To 30.11.2027. Tocilizumab, Fertigspritze, Fertigpen 2026-04-15
Germany Open House Medicinal Discount Contracts Natalizumab In The Delivery Form Cons.z.herst.e.inf.lsg. , Atc L04ag03 2026-04-15
Germany The Kkh (kaufmännische Krankenkasse) Aims To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Companies For The Active Ingredient(s) Mentioned In The Tender Within The Framework Of An ''open-hous 2026-04-15
Germany Open House Drug Discount Agreements For The Active Ingredient Fondaparinux, Atc B01ax05 2026-04-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Tocilizumab (exclusively Infusion Solution Concentrate), Atc L04ac07 For The Period December 1st, 2025 - November 30th, 2027 2026-04-15
Whats app